Amneal Pharmaceuticals, Inc.AMRXNASDAQ
LOADING
|||
EBITDA Over Time
Trending lower, above historical average, modest growth trend.
Left:
||||
Earnings before interest, taxes, depreciation, and amortization
Latest
$439.77M
↑ 42% above average
Average (9y)
$309.38M
Historical baseline
Range
High:$500.78M
Low:$-19.67M
CAGR
+6.4%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $439.77M | -12.2% |
| 2023 | $500.78M | +13.8% |
| 2022 | $440.21M | +9.8% |
| 2021 | $401.10M | +16.1% |
| 2020 | $345.61M | +122.7% |
| 2019 | $155.20M | +888.9% |
| 2018 | $-19.67M | -107.3% |
| 2017 | $271.13M | -11.7% |
| 2016 | $306.97M | +21.5% |
| 2015 | $252.68M | - |